4.5 Review

The enigma of yellow fever in East Africa

期刊

REVIEWS IN MEDICAL VIROLOGY
卷 18, 期 5, 页码 331-346

出版社

WILEY
DOI: 10.1002/rmv.584

关键词

-

类别

资金

  1. Tulane University Department of Tropical Medicine
  2. CDC Cooperative Agreement [T01/CCT622308-02]

向作者/读者索取更多资源

Despite a safe and effective vaccine, there are approximately 200 000 cases, including 30 000 deaths, due to yellow fever virus (YFV) each year, of which 90% are in Africa. The natural history of YFV has been well described, especially in West Africa, but in East Africa yellow fever (YF) remains characterised by unpredictable focal periodicity and a precarious potential for large epidemics. Recent outbreaks of YF in Kenya (1992-1993) and Sudan (2003 and 2005) are important because each of these outbreaks have involved the re-emergence of a YFV genotype (East Africa) that remained undetected for nearly 40 years and was previously unconfirmed in a clinically apparent outbreak. In addition, unlike West Africa and South America, YF has vet to emerge in urban areas of East Africa and be vectored by Aedes (Stegomyia) aegypti. This is a Significant public health concern in a region where the majority of the population remains unvaccinated. This review describes historical findings, highlights a number of disease indicators, and provides clarification regarding the natural history, recent emergence and future risk of YF in East Africa. Copyright (C) 2008 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据